Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W G Scott

Showing results (21-30 of 138) with videos related to

Pageof 14
Sort By:
Pharmacoeconomics|November 4, 1993
Annual costs of benign prostatic hyperplasia in New ZealandW G Scott, H M Scott
Pharmacoeconomics|December 9, 1995
Economic evaluation of vaccination against influenza in New ZealandW G Scott, H M Scott
Pharmacoeconomics|July 7, 1994
Critical leg ischaemia in New Zealand: economic cost of amputation versus intravenous iloprostH M Scott, W G Scott
Structure (London, England : 1993)|September 15, 1994
Transmembrane signalling and the aspartate receptorW G Scott, B L Stoddard
The New Zealand Medical Journal|October 27, 1995
Hysterectomy for nonmalignant conditions: cost to New Zealand societyH M Scott, W G Scott
Pharmacoeconomics|January 8, 1996
Heart failure. A decision analytic analysis of New Zealand data using the published results of the SOLVD Treatment Trial. Studies of Left Ventricular DysfunctionW G Scott, H M Scott
Methods in Enzymology|June 1, 2000
Conventional and time-resolved ribozyme X-ray crystallographyW G Scott, J B Murray
Nucleic Acids Symposium Series|January 1, 1995
The crystal structure of an all-RNA hammerhead ribozymeW G Scott, J T Finch, A Klug
Pharmacoeconomics|October 5, 1993
Roxithromycin vs cefaclorT Hughes, W G Scott, H M Scott
Cell|June 30, 1995
The crystal structure of an all-RNA hammerhead ribozyme: a proposed mechanism for RNA catalytic cleavageW G Scott, J T Finch, A Klug
Pageof 14

Showing results (21-30 of 138) with videos related to

Sort By:
Pageof 14
Pharmacoeconomics|November 4, 1993
Annual costs of benign prostatic hyperplasia in New ZealandW G Scott, H M Scott
Pharmacoeconomics|December 9, 1995
Economic evaluation of vaccination against influenza in New ZealandW G Scott, H M Scott
Pharmacoeconomics|July 7, 1994
Critical leg ischaemia in New Zealand: economic cost of amputation versus intravenous iloprostH M Scott, W G Scott
Structure (London, England : 1993)|September 15, 1994
Transmembrane signalling and the aspartate receptorW G Scott, B L Stoddard
The New Zealand Medical Journal|October 27, 1995
Hysterectomy for nonmalignant conditions: cost to New Zealand societyH M Scott, W G Scott
Pharmacoeconomics|January 8, 1996
Heart failure. A decision analytic analysis of New Zealand data using the published results of the SOLVD Treatment Trial. Studies of Left Ventricular DysfunctionW G Scott, H M Scott
Methods in Enzymology|June 1, 2000
Conventional and time-resolved ribozyme X-ray crystallographyW G Scott, J B Murray
Nucleic Acids Symposium Series|January 1, 1995
The crystal structure of an all-RNA hammerhead ribozymeW G Scott, J T Finch, A Klug
Pharmacoeconomics|October 5, 1993
Roxithromycin vs cefaclorT Hughes, W G Scott, H M Scott
Cell|June 30, 1995
The crystal structure of an all-RNA hammerhead ribozyme: a proposed mechanism for RNA catalytic cleavageW G Scott, J T Finch, A Klug
Pageof 14